武汉费斯德生物科技有限公司, NewEast Biosciences 中国办事处
武汉费斯德生物科技有限公司是美国NewEast Biosciences在中国的办事处。NewEast Biosciences 在十二年前率先研发俩种独特的抗体。这俩种抗体仅仅识别活性的GTP酶或者突变的Oncogene。 GTP酶涉及(1)响应细胞表面受体激活的信号转导,包括跨膜受体,例如介导味觉、嗅觉和视觉的那些,(2)核糖体的蛋白质生物合成,(3)调节细胞分化、增殖、分裂和运动,(4)蛋白质通过膜的易位,(5)细胞内囊泡的运输,以及囊泡介导的分泌和摄取,通过GTP酶控制囊泡外壳组装。Oncogene侧是诱发癌症的基因。
我公司将向你提供以下的独一无二的三种抗体或者试剂盒: (1) 仅识别 GTP酶的活性构型的产品, 它可以让你能够量化GTP酶在细胞中的活性和分布。(2) 识别突变 Oncogene蛋白, 但不认识相应野生型的抗体。 (3) 对 cAMP 和 cGMP 具有超亲和力(无需乙酰化)ELISA检测试剂盒。这些产品被将近一千篇同行评议的文章所引用。
¥2,850.00
货号: N263199 | ||||
产品全名: Phospho-TAOK1/2/3 (Ser181/Ser181/Ser177) 兔单克隆抗体 | ||||
基因符号 DPK; JIK; hKFC-A; MAP3K18 | ||||
UNIPROT ID: Q7L7X3/Q9H2K8/Q9UL54 | ||||
背景: Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. | ||||
抗原: A synthetic phosphopeptide corresponding to residues surrounding Ser181 of human TAOK1 | ||||
经过测试的应用: WB,IHC-P | ||||
推荐稀释比: WB: 1/500-1/1000 IHC: 1/50-1/100 | ||||
种属反应性: Rabbit | ||||
克隆性: Rabbit Monoclonal | ||||
克隆编号: R04-3I5 | ||||
分子量: Calculated MW: 116 kDa; Observed MW: 105,116,138 kDa | ||||
亚型: IgG | ||||
纯化: Affinity Purified | ||||
种属反应性: Human, Mouse and Rat | ||||
Modification: Phosphorylated | ||||
成分: PBS (without Mg2+ and Ca2+), pH 7.3 containing 50% glycerol, 0.5% BSA and 0.02% sodium azide | ||||
研究领域: – | ||||
储存和运输: Store at -20°C. Avoid repeated freezing and thawing | ||||
|